Novel therapies in the search for a cure for Huntington's disease.
暂无分享,去创建一个
[1] F. Gage,et al. Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum , 1984, Nature.
[2] K. Fischbeck,et al. CREB-binding protein sequestration by expanded polyglutamine. , 2000, Human molecular genetics.
[3] D. Housman,et al. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[4] D. Riche,et al. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] Ole A. Andreassen,et al. Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease , 2000, The Journal of Neuroscience.
[6] F. Vingerhoets,et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease , 1995, Annals of neurology.
[7] A. Bjo¨rklund,et al. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants , 1979, Brain Research.
[8] R. Ridley,et al. Functional integration of striatal allografts in a primate model of Huntington's disease , 1998, Nature Medicine.
[9] Björn Gustavii,et al. Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease , 1997, Annals of neurology.
[10] B J Hoffer,et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. , 1979, Science.
[11] Huda Y. Zoghbi,et al. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1 , 2000, Nature Neuroscience.
[12] Vincent Frouin,et al. Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients , 1995, Annals of neurology.
[13] C D Marsden,et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. , 1990, Science.
[14] P R Sanberg,et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. , 1995, The New England journal of medicine.
[15] J. Penney,et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease , 1999, Nature.
[16] F. Gage,et al. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cells implanted in different brain sites , 1983 .
[17] Françoise Condé,et al. Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease , 1998, Nature Medicine.
[18] J. MacMillan. Functional Neural Transplantation , 1995 .
[19] Y. Samson,et al. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. , 1994, Brain : a journal of neurology.
[20] T. Deacon,et al. Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathology. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Hersch,et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease , 2000, Nature Medicine.
[22] I. Whishaw,et al. Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions , 1987, Brain Research.
[23] A. Björklund,et al. Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum—III. Efferent projecting graft neurons and their relation to host afferents within the grafts , 1989, Neuroscience.